464311000001103: Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\UK product\Virtual medicinal product\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\UK product\Virtual therapeutic moiety\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Bendroflumethiazide\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing only bendroflumethiazide in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet\Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

16253101000001114 Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

16253201000001119 Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Is a	Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has active ingredient	Bendrofluazide - chemical	false	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has specific active ingredient	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets	Is pack of	False	Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier
Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
16253101000001114	Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
16253201000001119	Bendroflumethiazide 2.5mg tablets (IVAX Pharmaceuticals UK Ltd)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module